THOMPSON MATTHEW (Chief Medical Officer) sold 29.3% of their position (21.89K shares) of ENDOLOGIX INC /DE/ on the open market
Open‑market sale worth $1.9K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/14/2020ACC: 0001013606-20-000167
Officer· Chief Medical Officer
Since Dec 2018
-21.89K
Net shares
Net seller
$1.9K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
21.89K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−21.89K
Price / share
$0.09
Trade value
$1.93K
% of position
29.3%
8/12/2020
74.77K→52.88K
Total
Net shares
−21.89K
Net value
-$1.93K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/12/2020 | S · Sale | −21.89K | $0.09 | $1.93K | 29.3% | 74.77K | 52.88K |
| Total | −21.89K | -$1.93K | ||||||
Derivative Transactions0
No derivative transactions reported